This proposal is based on a model of urothelial cancer in which tumors develop along two histologic and molecular pathways: Lowgrade superficialtumors (pTaGi), which have frequent recurrences but rarely progress to muscle invasion;and high grade tumors which present either with early invasion into the lamina propria (pTiGs), or with more extensive muscle invasion (pT2-T4).We and others have identified a number of candidate genes and chromosomal alterations which are associated with these different pathways, and with clinical outcome.We hypothesize that overall genomicinstability and specificgenomic alterations are associated with environmental risk factors and with patient outcome. The overall design ofthis study is to characterize over 800 bladder tumors by array CGHandgene-specific analyses to define associations of molecular alterations with environmental exposures and with clinical outcome. These tumors have alreadybeen collected with associated data by our Spanish and NCI collabor- ators. Wewill validate associations between genomicalterations and patient outcome on a separate setof tumors collected as part ofthe International Bladder Tumor Marker Group. Specifically,we propose to:
Aim i. Identify molecular alterations associated with environmental exposures in bladder cancers from the Spanish/NCI EPICURO Study. lA) Characterizemolecular and genomic alterations in 250 pTa/Gi and 250 pT2-pT4/Gs tumors. Fraction genome altered and loci of specificalteration including DNA amplifications and homozygousdeletions will be studied by array-CGH,expression signature by quantitative RT-PCR, and sequencing will identify mutations in pss and FGFRs. iB) Identify associations between environmental exposures and genomic/geneticalterations in the pTa/Gi and pT2-pT4 tumors applying aCase-Case- Control study design. Exposures to be tested willbe tobacco smoke and trihalomethanes, which showed the strongest effects in the Case-Control study.
Aim 2. Identify genomic and gene-specific alterations associated with patient outcome in both pTa and pT2-T4 tumor groups from the EPICURO study. Array-basedCGH and gene-specificexpression analyses will be tested to confirmgenetic signatures predictive of patient outcome.
Aims. Asecond cohort of 300 pTs muscle invasive tumors will be used to validate the predictive signatures tested in Aim 2. These tumors are being collected as part of International Bladder TumorMarker Study to evaluatepredictive markers in urothelial cancer. Relevance: Bladdercancer is a major cause of morbidity and mortality in the United States and internationally and is among the top 5 in cancer incidence. This study will identify whether environmental exposures lead to geneticalterations in tumors, and whether such alterations predict patient outcome.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Epidemiology of Cancer Study Section (EPIC)
Program Officer
Tricoli, James
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Internal Medicine/Medicine
Schools of Medicine
San Francisco
United States
Zip Code
Tajuddin, S M; Amaral, A F S; Fernández, A F et al. (2014) LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk. Br J Cancer 110:2123-30
Figueroa, Jonine D; Ye, Yuanqing; Siddiq, Afshan et al. (2014) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 23:1387-98
Fu, Yi-Ping; Kohaar, Indu; Moore, Lee E et al. (2014) The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res 74:5808-18
de Maturana, Evangelina López; Chanok, Stephen J; Picornell, Antoni C et al. (2014) Whole genome prediction of bladder cancer risk with the Bayesian LASSO. Genet Epidemiol 38:467-76
Real, Francisco X; Boutros, Paul C; Malats, Núria (2014) Next-generation sequencing of urologic cancers: next is now. Eur Urol 66:4-7
Pineda, Silvia; Milne, Roger L; Calle, M Luz et al. (2014) Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis. PLoS One 9:e89952
Figueroa, Jonine D; Han, Summer S; Garcia-Closas, Montserrat et al. (2014) Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis 35:1737-44
Tajuddin, Salman M; Amaral, Andre F S; Fernandez, Agustin F et al. (2013) Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. Environ Health Perspect 121:650-6
Garcia-Closas, Montserrat; Rothman, Nathaniel; Figueroa, Jonine D et al. (2013) Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res 73:2211-20
Menashe, Idan; Figueroa, Jonine D; Garcia-Closas, Montserrat et al. (2012) Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One 7:e29396

Showing the most recent 10 out of 16 publications